BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24917491)

  • 1. Cranial metastatic alveolar rhabdomyosarcoma mimicking hematological malignancy in an adolescent boy.
    Patiroglu T; Isik B; Unal E; Canoz O; Deniz K; Kosemehmetoglu K; Karakukcu M; Ozdemir MA
    Childs Nerv Syst; 2014 Oct; 30(10):1737-41. PubMed ID: 24917491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alveolar rhabdomyosarcoma of unknown origin mimicking acute leukemia at the initial presentation].
    Yamaguchi K; Koga Y; Suminoe A; Saito Y; Matsuzaki A; Kanno S; Takimoto T; Suda M; Oda Y; Muto T; Takatsuki H; Hara T
    Rinsho Ketsueki; 2007 Apr; 48(4):315-20. PubMed ID: 17515123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
    Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
    J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
    Hu Q; Yuan Y; Wang C
    PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study.
    Hakozaki M; Hojo H; Tajino T; Yamada H; Kikuchi S; Kikuta A; Konno S; Abe M
    Hum Cell; 2013 Dec; 26(4):149-54. PubMed ID: 23797277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.
    Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R
    Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.
    Zhang Y; Wang C
    Oncogene; 2011 Aug; 30(32):3549-62. PubMed ID: 21423212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
    Parham DM; Qualman SJ; Teot L; Barr FG; Morotti R; Sorensen PH; Triche TJ; Meyer WH;
    Am J Surg Pathol; 2007 Jun; 31(6):895-901. PubMed ID: 17527077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete mimicry: a case of alveolar rhabdomyosarcoma masquerading as acute leukemia.
    Imataki O; Uemura M; Uchida S; Yokokura S; Takeuchi A; Ishikawa R; Kondo A; Seo K; Kadowaki N
    Diagn Pathol; 2017 Nov; 12(1):77. PubMed ID: 29096655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Rudzinski ER; Teot LA; Anderson JR; Moore J; Bridge JA; Barr FG; Gastier-Foster JM; Skapek SX; Hawkins DS; Parham DM
    Am J Clin Pathol; 2013 Jul; 140(1):82-90. PubMed ID: 23765537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells.
    Liu L; Wang YD; Wu J; Cui J; Chen T
    BMC Cancer; 2012 Apr; 12():154. PubMed ID: 22533991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.
    Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C
    Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
    Charytonowicz E; Cordon-Cardo C; Matushansky I; Ziman M
    Cancer Lett; 2009 Jul; 279(2):126-36. PubMed ID: 19008039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations.
    Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ
    Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
    Davicioni E; Finckenstein FG; Shahbazian V; Buckley JD; Triche TJ; Anderson MJ
    Cancer Res; 2006 Jul; 66(14):6936-46. PubMed ID: 16849537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of the PAX3-FOXO1 fusion gene in circulating tumor-derived DNA in a case of alveolar rhabdomyosarcoma.
    Eguchi-Ishimae M; Tezuka M; Kokeguchi T; Nagai K; Moritani K; Yonezawa S; Tauchi H; Tokuda K; Ishida Y; Ishii E; Eguchi M
    Genes Chromosomes Cancer; 2019 Aug; 58(8):521-529. PubMed ID: 30739374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pax3-fkhr and pax7-fkhr fusion genes impact outcome of alveolar rhabdomyosarcoma in children.
    Kazanowska B; Reich A; Stegmaier S; Békássy AN; Leuschner I; Chybicka A; Koscielniak E
    Fetal Pediatr Pathol; 2007; 26(1):17-31. PubMed ID: 17613043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.
    Barr FG; Qualman SJ; Macris MH; Melnyk N; Lawlor ER; Strzelecki DM; Triche TJ; Bridge JA; Sorensen PH
    Cancer Res; 2002 Aug; 62(16):4704-10. PubMed ID: 12183429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Credentialing a preclinical mouse model of alveolar rhabdomyosarcoma.
    Nishijo K; Chen QR; Zhang L; McCleish AT; Rodriguez A; Cho MJ; Prajapati SI; Gelfond JA; Chisholm GB; Michalek JE; Aronow BJ; Barr FG; Randall RL; Ladanyi M; Qualman SJ; Rubin BP; LeGallo RD; Wang C; Khan J; Keller C
    Cancer Res; 2009 Apr; 69(7):2902-11. PubMed ID: 19339268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options.
    Brown RE; Buryanek J; Katz AM; Paz K; Wolff JE
    Oncotarget; 2016 Jul; 7(29):46263-46272. PubMed ID: 27323832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.